Effects of Low-Doses Aspirin on Clinical Outcome and Disease Progression in Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumors: Results of a Multicentric Retrospective Study

被引：0
|
作者：
Massironi, S. [1 ]
Pusceddu, S. [2 ,3 ]
Cavalcoli, F. [4 ]
Zilli, A. [5 ]
Tamagno, G. [6 ]
Femia, D. [2 ,3 ]
Prinzi, N. [2 ,3 ]
Ciafardini, C. [1 ]
Conte, D. [4 ]
机构：
[1] Fdn IRCCS Ca Granda, Osped Maggiore Policlin, Milan, Italy
[2] Fdn IRCCS, Ist Tumori Milano, Milan, Italy
[3] Enets Ctr Excellence, Unit 1, Med Oncol, Milan, Italy
[4] Univ Milan, Pathophysiol & Transplantat, Milan, Italy
[5] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy
[6] Mater Misericordiae Univ Hosp, Dept Endocrinol Diabet, Dublin, Ireland
来源：
NEUROENDOCRINOLOGY | 2017年 / 105卷
关键词：
nen; asa;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E30
引用
收藏
页码：91 / 91
页数：1
相关论文
共 11 条
  • [1] EFFECTS OF LOW-DOSES ASPIRIN ON CLINICAL OUTCOME AND DISEASE PROGRESSION IN PATIENTS WITH GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE TUMORS: RESULTS OF A MULTICENTRIC RETROSPECTIVE STUDY
    Massironi, S.
    Pusceddu, S.
    Cavalcoli, F.
    Zilli, A.
    Tamagno, G.
    Femia, D.
    Prinzi, N.
    Ciafardini, C.
    Conte, D.
    [J]. DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E162 - E163
  • [2] RISK STRATIFICATION USING OCTREOTIDE TEST FOR PATIENTS WITH GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE TUMORS: RESULTS OF PROSPECTIVE VALIDATION OF THE TEST
    Massironi, S.
    Spampatti, M. P.
    Rossi, R. E.
    Conte, D.
    Ciafardini, C.
    Peracchi, M.
    [J]. DIGESTIVE AND LIVER DISEASE, 2011, 43 : S170 - S170
  • [3] SECOND PRIMARY NEOPLASMS IN PATIENTS WITH GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASMS (GEP-NEN): DATA FROM A RETROSPECTIVE ITANET STUDY
    Massironi, S.
    Campana, D.
    Pusceddu, S.
    Albertelli, M.
    Faggiano, A.
    Panzuto, F.
    Smiroldo, V.
    Andreasi, V.
    Rossi, R. E.
    Maggio, I.
    Torchio, M.
    Ambrosetti, E.
    Modica, R.
    Rinzivillo, M.
    Carnaghi, C.
    Partelli, S.
    Fanetti, I.
    Lamberti, G.
    Corti, F.
    Dotto, A.
    Colao, A.
    Annibale, B.
    Falconi, M.
    Invernizzi, P.
    [J]. DIGESTIVE AND LIVER DISEASE, 2020, 52 : S100 - S101
  • [4] Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian Epidemiological study: THE NET MANAGEMENT STUDY
    Faggiano, A.
    Ferolla, P.
    Grimaldi, F.
    Campana, D.
    Manzoni, M.
    Davi, M. V.
    Bianchi, A.
    Valcavi, R.
    Papini, E.
    Giuffrida, D.
    Ferone, D.
    Fanciulli, G.
    Arnaldi, G.
    Franchi, G. M.
    Francia, G.
    Fasola, G.
    Crino, L.
    Pontecorvi, A.
    Tomassetti, P.
    Colao, A.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2012, 35 (09) : 817 - 823
  • [5] Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian Epidemiological study: THE NET MANAGEMENT STUDY
    A. Faggiano
    P. Ferolla
    F. Grimaldi
    D. Campana
    M. Manzoni
    M. V. Davì
    A. Bianchi
    R. Valcavi
    E. Papini
    D. Giuffrida
    D. Ferone
    G. Fanciulli
    G. Arnaldi
    G. M. Franchi
    G. Francia
    G. Fasola
    L. Crinò
    A. Pontecorvi
    P. Tomassetti
    A. Colao
    [J]. Journal of Endocrinological Investigation, 2012, 35 : 817 - 823
  • [6] Effects of low-dose aspirin on clinical outcome and disease progression in patients with gastroenteropancreatic neuroendocrine neoplasm
    Cavalcoli, Federica
    Pusceddu, Sara
    Zilli, Alessandra
    Tamagno, Gianluca
    Femia, Daniela
    Prinzi, Natalie
    Travers, John
    Consonni, Dario
    Ciafardini, Clorinda
    Conte, Dario
    Massironi, Sara
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (09) : 1111 - 1117
  • [7] GA-68 DOTATATE PET IN GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASMS: ACCURATE DISEASE ASSESMENT AND CLINICAL IMPLICATIONS IN A LARGE PATIENTS' COHORT
    Kamieniarz, Lukasz
    O'Mahony, Luke Furtado
    Cox, Nick
    Narayan, Akshay
    Bhatt, Ankit
    Leigh, Charlotte
    Miah, Lukon
    Navalkissoor, Shaunak
    Mandair, Dalvinder
    Caplin, Martyn
    Toumpanakis, Christos
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S133 - S134
  • [8] Early results of 212Pb-VMT-α-NET Targeted Alpha Therapy in Metastatic Gastro-entero-pancreatic Neuroendocrine Tumors: First in Human Clinical Experience on Safety and Efficacy
    Malik, D.
    Sen, I.
    Thakral, P.
    Das, S.
    Schultz, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S313 - S313
  • [9] Metformin impact on progression-free survival in diabetic patients with advanced pancreatic neuroendocrine tumors (pNET) receiving everolimus and/or somatostatin analogues. The PRIME-NET (Pancreatic multicentric, Retrospective, Italian MEtformin) study
    Pusceddu, S.
    Marconcini, R.
    Spada, F.
    Cavalcoli, F.
    Ibrahim, T.
    Brizzi, M. P.
    Brighi, N.
    Faggiano, A.
    Puliafito, I.
    Delle Fave, G.
    Perfetti, V.
    Luppi, G.
    Carnaghi, C.
    Razzore, P.
    Davi, M. V.
    Cauchi, C.
    Duro, M.
    Di Maio, M.
    Buzzoni, R.
    Femia, D.
    De Braud, F.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [10] Metformin impact on progression-free survival in diabetic patients with advanced pancreatic neuroendocrine tumors (pNET) receiving everolimus and/or somatostatin analogues. The PRIME-NET (Pancreatic multicentric, Retrospective, Italian MEtformin) study
    Pusceddu, S.
    Marconcini, R.
    Spada, F.
    Massironi, S.
    Bongiovanni, A.
    Brizzi, M. P.
    Brighi, N.
    Colao, A.
    Giuffrida, D.
    Delle Fave, G.
    Cingarlini, S.
    Aroldi, F.
    Antonuzzo, L.
    Berardi, R.
    Catena, L.
    de Divitis, C.
    Ermacora, P.
    Di Maio, M.
    Buzzoni, R.
    de Braud, F.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
12